Literature DB >> 10830421

Parkinsonism, dystonia, and hemiatrophy.

P E Greene1, S B Bressman, B Ford, K Hyland.   

Abstract

Hemiatrophy has been reported in association with a variety of neurologic conditions, including parkinsonism. Patients with the hemiparkinson-hemiatrophy syndrome (HP-HA) have asymmetric parkinsonism with limb atrophy on the more affected side. Several authors have suggested that asymmetric brain damage early in life results in both atrophy and parkinsonism. Dopa-responsive dystonia (DRD) is a disease in which a deficiency of tetrahydrobiopterin, or, less commonly, of tyrosine hydroxylase, results in levodopa-responsive dystonia with parkinson features in children. We have recently identified four patients with DRD who had asymmetric dystonia and limb atrophy on the more affected side. Based on these patients, we suggest that a deficiency of the nigrostriatal dopamine system may, by itself, be sufficient to cause body atrophy and may underlie the limb atrophy in both DRD and HP-HA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10830421     DOI: 10.1002/1531-8257(200005)15:3<537::AID-MDS1018>3.0.CO;2-3

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  2 in total

1.  Asymmetrical leg atrophy in levodopa-responsive dystonia due to a novel GTP cyclohydrolase mutation.

Authors:  Eoin Mulroy; Allan McCarthy; Tim Lynch; Danny Costello; Owen A Ross
Journal:  Mov Disord       Date:  2014-01-28       Impact factor: 10.338

2.  Clinical Heterogeneity in Cerebral Hemiatrophy Syndromes.

Authors:  Eva Reiter; Beatrice Heim; Christoph Scherfler; Christoph Mueller; Michael Nocker; Jean-Pierre Ndayisaba; Wolfgang Loescher; Klaus Seppi; Andrew J Lees; Thomas Warner; Werner Poewe; Gregor K Wenning; Atbin Djamshidian
Journal:  Mov Disord Clin Pract       Date:  2016-01-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.